ExoZymes Inc. Files 8-K on December 11 Event
Ticker: EXOZ · Form: 8-K · Filed: Dec 12, 2025 · CIK: 2010788
| Field | Detail |
|---|---|
| Company | Exozymes Inc. (EXOZ) |
| Form Type | 8-K |
| Filed Date | Dec 12, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-event, disclosure
Related Tickers: EXZ
TL;DR
EXZ filed an 8-K for an event on 12/11 - details pending.
AI Summary
ExoZymes Inc. filed an 8-K on December 12, 2025, reporting an event that occurred on December 11, 2025. The filing indicates a change in the company's status or operations, though specific details of the event are not provided in this excerpt. The company, formerly Invizyne Technologies Inc., is incorporated in Nevada and based in Monrovia, California.
Why It Matters
This 8-K filing signals a material event for ExoZymes Inc., requiring disclosure to investors and the public. The nature of this event could impact the company's operations, financial standing, or strategic direction.
Risk Assessment
Risk Level: medium — The filing of an 8-K indicates a significant event has occurred, but the lack of specific details in this excerpt creates uncertainty about the nature and impact of the event.
Key Players & Entities
- EXOZYMES INC. (company) — Registrant
- Invizyne Technologies Inc (company) — Former company name
- December 11, 2025 (date) — Date of earliest event reported
- December 12, 2025 (date) — Filing date
- Nevada (jurisdiction) — State of incorporation
- Monrovia, CA (location) — Principal executive offices
FAQ
What specific event occurred on December 11, 2025, that necessitated this 8-K filing?
The provided excerpt does not specify the exact event that occurred on December 11, 2025, only that it is the earliest event reported.
What is the primary business of ExoZymes Inc.?
ExoZymes Inc. is in the business of Biological Products (No Diagnostic Substances), with SIC code 2836.
When did ExoZymes Inc. change its name from Invizyne Technologies Inc.?
The company changed its name from Invizyne Technologies Inc. on February 5, 2024.
Where are ExoZymes Inc.'s principal executive offices located?
The principal executive offices of ExoZymes Inc. are located at 750 Royal Oaks Drive, Suite 106, Monrovia, CA 91016.
What is the SEC file number for ExoZymes Inc.?
The SEC file number for ExoZymes Inc. is 001-42204.
Filing Stats: 390 words · 2 min read · ~1 pages · Grade level 10.4 · Accepted 2025-12-11 19:43:53
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 13KB
- 0001493152-25-027327.txt ( ) — 217KB
- exoz-20251211.xsd (EX-101.SCH) — 3KB
- exoz-20251211_lab.xml (EX-101.LAB) — 33KB
- exoz-20251211_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibits Description of Exhibit 99.1 Press Release dated December 11, 2025, related to NCT production. 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 12 , 2025 EXOZYMES INC. By /s/ Fouad Nawaz Fouad Nawaz, Vice President, Finance